KLK3 and pachyonychia congenita: The majority of patients had high-risk features at PC diagnosis: median prostate-specific antigen (PSA) at diagnosis was 65.5 ng/ml (range: 3.9–784.7 ng/ml), 82% were Gleason grade group ≥ 4, and 68% had perineural invasion (PNI).